Medicover AB (LTS:0RPS) Long-Term Debt: kr6,768 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0RPS Medicover AB LTS:0RPS
90 GF Score
Price kr228.50
GF Value kr233.87
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Medicover AB Long-Term Debt?

Medicover AB LTS:0RPS +2.01% 90 Long-Term Debt is kr6,768 Mil as of Mar. 2026. GuruFocus rates LTS:0RPS with a GF Score™ of 90/100 and a GF Value™ of kr233.87 (Fairly Valued). The stock has 5 warning signs investors should review.

Medicover AB's Long-Term Debt for the quarter that ended in Mar. 2026 was kr6,768 Mil.

Medicover AB's quarterly Long-Term Debt declined from Sep. 2025 (kr7,459 Mil) to Dec. 2025 (kr6,756 Mil) but then increased from Dec. 2025 (kr6,756 Mil) to Mar. 2026 (kr6,768 Mil).

Medicover AB's annual Long-Term Debt increased from Dec. 2023 (kr4,546 Mil) to Dec. 2024 (kr6,247 Mil) and increased from Dec. 2024 (kr6,247 Mil) to Dec. 2025 (kr6,756 Mil).

Medicover AB  (LTS:0RPS) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Medicover AB Long-Term Debt Related Terms

Medicover AB Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Medicover AB's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medicover AB Long-Term Debt Chart

Medicover AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,854.61 5,204.39 4,546.01 6,247.07 6,755.74

Medicover AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6,133.36 8,213.43 7,458.56 6,755.74 6,767.63
LTS:0RPS
90GF Score
Medicover AB LTS:0RPS
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of kr6,768 Mil mean?
Medicover AB (LTS:0RPS) has a Long-Term Debt of kr6,768 Mil as of Mar. 2026.
Is Medicover AB's Long-Term Debt too high?
Medicover AB's current Long-Term Debt is kr6,768 Mil. Overall, Medicover AB has a GF Score™ of 90/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Medicover AB's Long-Term Debt compare to HCA and THC?
Medicover AB's Long-Term Debt of kr6,768 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Healthcare Providers & Services company?
A good Long-Term Debt depends on the Healthcare Providers & Services industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Medicover AB's current Long-Term Debt is kr6,768 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medicover AB stock overvalued right now?
Based on GuruFocus' analysis, Medicover AB (LTS:0RPS) is currently considered Fairly Valued. The stock's GF Value™ is kr233.87, compared to a current price of kr228.50 — trading 2.3% below its estimated fair value. The current Long-Term Debt is kr6,768 Mil. Medicover AB's overall GF Score™ is 90/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Medicover AB (LTS:0RPS), the current Long-Term Debt is kr6,768 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medicover AB (LTS:0RPS) Overvalued in 2026?

Based on GuruFocus' analysis, Medicover AB stock appears to be undervalued. The current stock price of kr228.50 is trading 2.3% below its estimated GF Value™ of kr233.87. GuruFocus considers Medicover AB to be Fairly Valued.

Key valuation signals for LTS:0RPS:

  • Long-Term Debt: kr6,768 Mil
  • GF Value™: kr233.87 vs. price of kr228.50 (2.3% below fair value)
  • GF Score™: 90/100 with 5 warning signs

No single metric tells the full story. See the LTS:0RPS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medicover AB Business Description

Address Riddargatan 12A, P.O. Box 5283, Stockholm, SWE, 102 46
Medicover AB is an international healthcare and diagnostic services provider. It offers a broad spectrum of healthcare services via an extensive network of ambulatory clinics, hospitals, specialty-care facilities, and laboratories. Medicover offers its services through two reportable segments: Healthcare Services, which generates the maximum revenue, and Diagnostic Services. Diagnostic Services offer a broad range of laboratory testing in all clinical pathology areas, and Healthcare Services offer medical care and related services by operating on an Integrated Healthcare and Fee-For-Service model across different countries. Geographically, the company derives maximum revenue from Germany, and the rest from Poland, India, Ukraine, Romania, and other countries.
90GF Score

Get the complete analysis for LTS:0RPS

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr228.50
Price
kr233.87
GF Value